全文获取类型
收费全文 | 152481篇 |
免费 | 10811篇 |
国内免费 | 1548篇 |
专业分类
耳鼻咽喉 | 1804篇 |
儿科学 | 3617篇 |
妇产科学 | 2770篇 |
基础医学 | 19420篇 |
口腔科学 | 3236篇 |
临床医学 | 15514篇 |
内科学 | 30498篇 |
皮肤病学 | 1993篇 |
神经病学 | 12807篇 |
特种医学 | 5855篇 |
外国民族医学 | 7篇 |
外科学 | 23614篇 |
综合类 | 4345篇 |
现状与发展 | 2篇 |
一般理论 | 184篇 |
预防医学 | 13341篇 |
眼科学 | 3336篇 |
药学 | 11316篇 |
10篇 | |
中国医学 | 874篇 |
肿瘤学 | 10297篇 |
出版年
2023年 | 944篇 |
2022年 | 1671篇 |
2021年 | 3299篇 |
2020年 | 2010篇 |
2019年 | 2930篇 |
2018年 | 3504篇 |
2017年 | 2590篇 |
2016年 | 2669篇 |
2015年 | 3428篇 |
2014年 | 4909篇 |
2013年 | 6948篇 |
2012年 | 10137篇 |
2011年 | 10827篇 |
2010年 | 6139篇 |
2009年 | 5500篇 |
2008年 | 9246篇 |
2007年 | 9854篇 |
2006年 | 9392篇 |
2005年 | 9520篇 |
2004年 | 8919篇 |
2003年 | 8396篇 |
2002年 | 8059篇 |
2001年 | 1644篇 |
2000年 | 1424篇 |
1999年 | 1832篇 |
1998年 | 1889篇 |
1997年 | 1561篇 |
1996年 | 1426篇 |
1995年 | 1380篇 |
1994年 | 1163篇 |
1993年 | 1100篇 |
1992年 | 949篇 |
1991年 | 948篇 |
1990年 | 828篇 |
1989年 | 790篇 |
1988年 | 840篇 |
1987年 | 814篇 |
1986年 | 804篇 |
1985年 | 878篇 |
1984年 | 929篇 |
1983年 | 887篇 |
1982年 | 1144篇 |
1981年 | 1167篇 |
1980年 | 971篇 |
1979年 | 659篇 |
1978年 | 677篇 |
1977年 | 603篇 |
1976年 | 521篇 |
1975年 | 476篇 |
1974年 | 479篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
101.
Jennifer M Griffith James R Sorenson J Michael Bowling Tracey Jennings-Grant 《Health education & behavior》2005,32(5):613-626
The Enhancing Patient Prenatal Education study tested the feasibility and educational impact of an interactive program for patient prenatal genetic screening and testing education. Patients at two private practices and one public health clinic participated (N = 207). The program collected knowledge and measures of anxiety before and after use of the tool. Time in various prenatal visit activities was collected prior to and after the introduction of the education tool. Providers completed an assessment of their experiences with patients who had used the program. Results indicate that patient knowledge significantly increased from pre to post (p = .0001) with no increase in anxiety (p = .31). Time in clinic activities, including overall visit time, increased. A majority of providers indicated that the program disrupted clinic flow. This assessment suggests that the program increases patient knowledge and does not increase patient anxiety. However, challenges remain to using this program in a clinic setting. 相似文献
102.
103.
104.
Effects of pegfilgrastim on normal biodistribution of 18F-FDG: preclinical and clinical studies. 总被引:1,自引:0,他引:1
Heather A Jacene Takayoshi Ishimori James M Engles Sophie Leboulleux Vered Stearns Richard L Wahl 《Journal of nuclear medicine》2006,47(6):950-956
The purpose of this study was to evaluate the effects of pegfilgrastim, a long-acting granulocyte colony-stimulating factor, on the normal biodistribution of (18)F-FDG in an animal model and in humans. METHODS: Two groups of 12 rats received a single subcutaneous injection of either normal saline or pegfilgrastim. One, 7, 14, and 21 d after injection, biodistribution studies were performed 1 h after (18)F-FDG injection. Sixteen breast cancer patients underwent baseline (18)F-FDG PET/CT and, approximately 1 wk after receiving 1 dose of docetaxel and adjunctive pegfilgrastim, follow-up (18)F-FDG PET/CT (scan 2). Standardized uptake values corrected for lean body mass (SUL) were determined for several normal organs before and after therapy. RESULTS: In rats, bone marrow (18)F-FDG uptake (standardized uptake value) was higher in the pegfilgrastim group 1 d after injection (mean +/- SD, 8.3 +/- 4.1 vs. 2.5 +/- 0.2, P < 0.05), whereas (18)F-FDG uptake in blood was lower (0.41 +/- 0.06 vs. 0.49 +/- 0.01, P < 0.05). In patients, mean SUL was higher in bone marrow (4.49 +/- 1.50 vs. 1.33 +/- 0.22, P < 0.0001), spleen (3.29 +/- 0.83 vs. 1.23 +/- 0.23, P < 0.0001), and liver (1.45 +/- 0.25 vs. 1.31 +/- 0.23, P = 0.01) but lower in brain (4.18 +/- 0.76 vs. 5.14 +/- 1.44, P < 0.01) on scan 2 than on the baseline scan. CONCLUSION: In both the animal model and humans, pegfilgrastim markedly increased bone marrow uptake of (18)F-FDG and reduced (18)F-FDG uptake in some normal tissues. These profound alterations in (18)F-FDG biodistribution induced by pegfilgrastim must be considered when one is evaluating quantitative (18)F-FDG PET scans for tumor response to therapy. 相似文献
105.
Factors influencing family physicians to enter rural practice: Does rural or urban background make a difference? 下载免费PDF全文
106.
107.
Preclinical and clinical investigations currently underway are employing novel strategies for combining vaccines with conventional and experimental anticancer therapies. To date, the FDA has not approved a therapeutic cancer vaccine. However, the results of recent investigations suggest an increasing role for vaccines in new models of combination therapy for many types of cancer. This article reviews and discusses therapeutic cancer strategies that employ vaccines in combination with local radiation, chemotherapy, hormone therapy, and anti-CTLA-4 mAb. Preclinical studies have shown that certain anticancer agents have immune modulatory effects that result in up-regulation of surface expression of MHC molecules, tumor-associated antigens, or Fas on malignant cells, rendering them more susceptible to immune destruction. Preliminary results of clinical studies using combination strategies have demonstrated a postvaccination antigen cascade, prolonged time to disease progression, and improved overall survival. Several larger randomized trials are ongoing, and more are required to support these findings. 相似文献
108.
James M Stringham Billy R Hammond Billy R Wooten D Max Snodderly 《Optometry and vision science》2006,83(12):887-894
PURPOSE: Macular pigment (MP) filters short-wavelength light before it reaches the visual pigments. At peak absorbance (460 nm), transmission of light through MP can range from almost 100% transmission to as little as 3%. As a result of the uneven topographic distribution of MP, spatial nonuniformities in visual perception would result if the visual system did not compensate for filtering differences across the central retina. This study characterizes compensation for different densities of MP. METHODS: Sixteen young subjects (aged 24-40 years) with a wide range of MP density were studied. Increment thresholds were measured at 440 and 500 nm in the center of the fovea and at 6 degrees to 7 degrees eccentricity using conditions chosen to isolate the pi-1 mechanism. For six of the subjects, increment thresholds were also obtained for eccentricities of 1 degrees , 1.75 degrees , and 3 degrees . MP density was measured using heterochromatic flicker photometry at the same locations as the increment thresholds. RESULTS: Peak sensitivity of the short-wavelength pathway across the central retina was constant despite MP density differences as large as 1.0 log unit. CONCLUSIONS: These results suggest that the visual system increases gain of the S-cone pathway to offset light absorption by MP. 相似文献
109.
Dyssynchronous ventricular contraction in severe heart failurecontributes to low cardiac output, worsening symptoms, and poorprognosis. Recognition of the effect of dyssynchrony in heartfailure, and the possibility of manipulating the sequence ofelectrical cardiac activation to improve the efficiency of mechanicalevents, led Cazeau et al. to attempt four-chamber pacing in1994.1 This early system could stimulate both atria and bothventricles extrinsically, and could dictate the temporal relationshipbetween atrial systole and ventricular systole, and the ventriculo-ventricularrelationship. Modern cardiac resynchronization therapy (CRT),involving pacing of the right and left ventricles, with rightatrial pacing to optimize atrio-ventricular delay, has evolvedrapidly from this beginning. Left bundle branch block (LBBB) on the surface electrocardiogram(ECG) has been considered a marker of mechanical dyssynchronyas it represents a delay in conduction of depolarization tothe left ventricle, with the greatest delay usually being in 相似文献
110.
James W Wheless 《Neuropsychiatric Disease and Treatment》2007,3(4):409-421
Epilepsy is a common pediatric neurologic disorder that is difficult to manage in a substantial portion of children. Levetiracetam (LEV) is a novel antiepileptic drug (AED) that has recently been approved as add-on treatment for various seizure types in epilepsy populations that include children: for refractory partial seizures in epilepsy patients ≥4 years old, for myoclonic seizures in juvenile myoclonic epilepsy patients ≥12 years old, and for primary generalized tonic-clonic seizures in idiopathic generalized epilepsy patients (≥6 years old with FDA approval; ≥12 years old with EMEA approval). A review of published pediatric studies indicates that the efficacy of LEV is best established for partial seizures; however, results from recent double-blind and open-label trials indicate that adjunctive LEV also controls generalized seizures – particularly myoclonic and generalized tonic-clonic – in children and adolescents with primary generalized epilepsy. LEV was well-tolerated in pediatric studies. The most common adverse events (AEs) reported were sedation related. Behavioral AEs were among the most commonly reported events in some trials; conversely, improvements in behavior and cognition were also frequently reported. LEV appears to be a safe and effective AED with unique characteristics that benefit the treatment of children with epilepsy. 相似文献